Sponsor pipeline

Celldex Therapeutics clinical trial pipeline

Get alerts when Celldex Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 2
2
Phase 3
4

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07266402 A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo… Chronic Inducible Urticaria Recruiting 2026-10-07
NCT07256392 Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With… Chronic Spontaneous Urticaria Enrolling by Invitation 2026-10-07
NCT06445023 A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria Chronic Spontaneous Urticaria Active, Not Recruiting 2026-03-25
NCT06455202 A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) Chronic Spontaneous Urticaria Active, Not Recruiting 2026-03-25
Phase 2
NCT06727552 A Study of Barzolvolimab in Patients With Atopic Dermatitis Atopic Dermatitis Active, Not Recruiting 2026-08-11
NCT06366750 A Study of Barzolvolimab in Patients With Prurigo Nodularis Prurigo Nodularis Active, Not Recruiting 2026-08-04
Phase 1
NCT07330778 A Study of CDX-622 in Participants With Mild to Moderate Asthma Mild to Moderate Asthma Recruiting 2026-07-02

Disease areas by active trials

Asthma (1) · Atopic Dermatitis (1)

Get alerts when Celldex Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free